White House Says It Will Meet Vaccine Goals Despite Pause In Johnson & Johnson Use
The NPR Politics Podcast
00:00
Assessing the Impact of the Johnson & Johnson Vaccine Pause
This chapter explores the consequences of pausing the Johnson & Johnson vaccine on U.S. vaccination efforts, focusing on public perception and logistical challenges. Despite setbacks, officials express confidence that vaccination goals can still be achieved with mRNA alternatives like Pfizer and Moderna.
Play episode from 09:49
Transcript
